Vasopressin and its analogues for the treatment of refractory hypotension in neonates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vasopressin and Its Analogues for the Treatment of Refractory Hypotension in Neonates." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439668/all/Vasopressin_and_its_analogues_for_the_treatment_of_refractory_hypotension_in_neonates.
Vasopressin and its analogues for the treatment of refractory hypotension in neonates. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439668/all/Vasopressin_and_its_analogues_for_the_treatment_of_refractory_hypotension_in_neonates. Accessed January 24, 2026.
Vasopressin and its analogues for the treatment of refractory hypotension in neonates. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439668/all/Vasopressin_and_its_analogues_for_the_treatment_of_refractory_hypotension_in_neonates
Vasopressin and Its Analogues for the Treatment of Refractory Hypotension in Neonates [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439668/all/Vasopressin_and_its_analogues_for_the_treatment_of_refractory_hypotension_in_neonates.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vasopressin and its analogues for the treatment of refractory hypotension in neonates
ID - 439668
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439668/all/Vasopressin_and_its_analogues_for_the_treatment_of_refractory_hypotension_in_neonates
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

